ARIA Programme Director Precision Bio
Supports United Kingdom precision medicine researchers advancing bio solutions for diagnosis and care delivery innovation.
ARIA Programme Director Precision Bio sits under the UK's Advanced Research and Invention Agency and backs precision biology tools. The call is director-led and points to a commercial audience rather than nonprofits or individuals. It gives ARIA a focused route for biotech-adjacent work rather than a general-purpose life-science line. The program is a grant route with awards from £200,000 to £5 million and a median award of £1 million. It is a one-off call rather than a recurring annual window, and it is open to for-profit applicants registered in the UK or abroad. The technical screen is pitched at TRL 2 to 5, which leaves room for early development without dropping into pure concept stage. The strongest fit is a company turning precision-biology tooling into something that can survive early development risk and still look commercially credible. Nonprofits and individuals are excluded, and applicants cannot stack funding on the same scope. In practice, that makes the route a good match for teams that need a substantial first tranche and can show a clear technical path from toolmaking to application.
No upcoming rounds verified. Cadence: One-off.